The Price Is Only the Beginning: What Healthcare Really Pays When It Changes Products

Why the cost of a healthcare product conversion extends far beyond the negotiated price

One of the easiest numbers to compare in healthcare supply chain is price.

Supplier A is $42. Supplier B is $38. Multiply the difference by annual volume, and the opportunity looks straightforward.

On paper, at least.

After years of evaluating products, negotiating agreements, working through conversions, and then watching what happens after implementation, I have learned to be cautious when the business case begins and ends with that calculation.

The purchase price matters. Of course it does. Health systems cannot ignore four dollars of savings multiplied across thousands of units, particularly in today's financial environment.

But the price we negotiate and the cost the organization ultimately absorbs are not always the same thing.

Changing a product can touch clinical practice, inventory, technology, education, distribution, contracting, data, workflow, and people. Some of those costs are obvious before the decision is made. Others do not appear until implementation is underway.

And some never appear on an invoice at all.

That is why a product conversion that looks like an easy savings opportunity can turn out to be anything but simple.

The Spreadsheet Usually Starts in the Right Place

There is nothing wrong with beginning with price.

If an organization purchases 20,000 units of something each year and a competing supplier can reduce the cost by $4 per unit, there is a legitimate $80,000 opportunity worth examining.

The problem comes when we stop there.

Before calling that $80,000 savings, I want to understand what has to happen for the organization to actually capture it.

Will existing inventory have to be depleted or written off? Does the new product require different accessories or consumables? Are there minimum purchase requirements? Does the change affect distribution or storage? Will clinicians need training? Is new equipment involved? Are interfaces or technology changes required? Does the conversion create additional labor somewhere else?

None of those questions automatically eliminate the opportunity.

They simply tell us whether the opportunity is really $80,000.

That is a different exercise from comparing two-unit prices.

Every Conversion Has a Footprint

Some conversions are genuinely easy. The products are clinically equivalent, workflows remain essentially unchanged, implementation requirements are minimal, and the organization can move from one supplier to another without much disruption.

Others have a much larger footprint.

Consider something used frequently in patient care. Changing it may affect thousands of clinicians across multiple hospitals. Education needs to be coordinated across shifts. Existing stock needs to be managed so the old and new products do not create confusion. Item files need to be updated. PAR locations may change. Preference cards may need attention. Distribution centers and distributors have to know when the transition occurs.

Now consider a product connected to equipment or technology.

The conversation expands again.

There may be capital requirements, biomedical engineering involvement, IT interfaces, cybersecurity review, installation, validation, service agreements, maintenance, construction, or workflow redesign.

A supplier may still offer the better solution.

But now we understand the decision we are actually making.

That is the point.

The Most Expensive Cost May Be Disruption

There is another cost that is much harder to place in a spreadsheet: organizational disruption.

Healthcare workers already operate in an environment of constant change. New systems. New processes. New equipment. New policies. Staffing changes. Regulatory requirements. Clinical initiatives.

Every conversion asks people to change something they already know how to do.

Sometimes that change is absolutely worth making.

But change consumes capacity.

A product that saves money while creating significant disruption for nursing, procedural teams, sterile processing, supply chain, or another operational group may have a very different value proposition than the initial sourcing analysis suggests.

This does not mean we should avoid change because it is inconvenient. That would make improvement nearly impossible.

It means the burden of change belongs in the decision.

If we are going to ask hundreds of people to do something differently, there should be enough value on the other side to justify it.

Clinical Preference Has an Economic Impact Too

This is where product conversions become especially interesting in healthcare.

Two products may appear equivalent from a sourcing perspective and feel very different to the people using them.

That difference matters.

If clinicians strongly resist the new product, several things can happen. Adoption may be slower than expected. Exceptions may increase. Departments may continue ordering the incumbent product. Workarounds can develop. Instead of standardizing the category, the organization may end up supporting both products.

Suddenly the anticipated savings begin to erode.

This is one reason clinical engagement should happen before the financial opportunity is declared a success.

The goal is not to give every individual unlimited product choice. Healthcare organizations need standardization, and clinical preference cannot be the only factor driving supply decisions.

But neither can it be ignored.

The strongest conversions balance clinical requirements with operational and financial realities. When clinicians understand why a change is being considered and have a meaningful role in evaluating whether the alternative meets patient-care needs, implementation tends to be much stronger.

That involvement is not an obstacle to savings.

Done well, it protects them.

Suppliers Should Understand the Cost of Conversion Too

This is an area where suppliers can distinguish themselves.

If you are asking a healthcare organization to replace an incumbent product, don't make the provider discover every implementation requirement after the agreement is signed.

Tell us what conversion actually takes.

What education is required? How long does implementation typically take? What happens to existing inventory? What resources will your team provide? Are there ancillary products we need to account for? What technology or equipment dependencies exist? What have other health systems underestimated during conversion?

That level of transparency builds credibility.

It also creates a much stronger business case because we can evaluate the opportunity with realistic assumptions rather than discovering hidden requirements halfway through implementation.

A supplier who understands the disruption associated with adopting its own solution is far more useful than one who only understands its price advantage.

The Provider Has to Be Equally Honest

Health systems also have a tendency to underestimate our own cost of change.

We identify a sourcing opportunity, negotiate the agreement, calculate the projected savings, and set an implementation date.

Then reality arrives.

The clinical team isn't ready. Existing inventory is larger than expected. Another major initiative is consuming IT resources. Education cannot happen on the original timeline. A department identifies a workflow issue that wasn't considered during evaluation.

None of this is particularly unusual.

The problem is when our business case assumed none of it would happen.

A more disciplined approach asks those questions before the savings number becomes a commitment.

Who needs to participate in the conversion?

What internal resources will be required?

How much inventory is currently on hand?

Are there competing initiatives?

What could delay adoption?

How will exceptions be managed?

When should savings realistically begin?

Those questions make the projected opportunity less exciting in some cases.

They also make it more believable.

Savings on Paper Are Not Savings in Practice

This may be the most important distinction.

Negotiated savings are an opportunity.

Implemented savings are a result.

If a sourcing team negotiates a lower price but only 60 percent of the organization converts, the original opportunity was never fully realized.

If the new product creates additional labor somewhere else, the net value changes.

If implementation is delayed six months, the first-year savings change.

If obsolete inventory has to be written off, the financial picture changes again.

That is why mature supply chain organizations need to follow initiatives beyond contract signature.

What did we expect?

What actually happened?

Did utilization move?

Did the organization standardize?

Were there unexpected costs?

Did the clinical or operational benefits materialize?

What did the organization actually save?

Those are value-realization questions, not sourcing questions alone.

And they are essential if supply chain wants credibility with Finance and operational leadership.

Sometimes the More Expensive Product Is the Better Decision

This is the part of the conversation that can make traditional price comparisons uncomfortable.

Sometimes the product with the higher unit price creates more value.

Perhaps it reduces procedure time. Maybe it requires less labor. It could eliminate another product entirely, reduce waste, improve standardization, prevent complications, improve throughput, or create a more reliable supply position.

Conversely, the lowest-priced product may introduce enough complexity elsewhere that the apparent savings are largely consumed.

Neither conclusion should be assumed.

That is why the evaluation has to extend beyond price.

Healthcare supply chain should not be in the business of buying the cheapest thing.

We should be helping the organization understand the total impact of the choices it makes.

That requires a broader lens.

Final Thoughts

Price will always matter. It should.

But one of the lessons healthcare supply chain learns with experience is that the number on the purchase order tells only part of the story.

Every significant product change has a footprint. Someone has to implement it. Someone has to learn it. Inventory has to move. Systems have to change. Clinicians have to adopt it. Operations have to absorb it.

The question is not whether those things make conversion too difficult.

The question is whether we have accounted for them when deciding what the opportunity is worth.

For providers, that means building business cases around realistic total impact rather than unit-price savings alone.

For suppliers, it means understanding that asking a health system to change products means asking an organization to change behavior.

And for both sides, it means recognizing that the best economic decision is not always found in the lowest number on the spreadsheet.

Sometimes the most important costs are the ones that never appeared there in the first place.

Continue your Professional Journey

Understanding healthcare supply chain requires seeing beyond the transaction. Product selection affects clinical practice, operations, inventory, technology, contracting, finance, and the people responsible for making change work.

That broader perspective is one of the reasons foundational healthcare supply chain knowledge matters for both providers and industry partners.

Ready to Take the Next Step?

📚 Download Free Resources
Explore practical tools and educational resources created for healthcare supply chain professionals and industry partners.

📧 Subscribe to The Hub Weekly
Get new articles and perspectives on the issues shaping healthcare supply chain and provider-supplier relationships.

🎓 Learn More About the Healthcare Supply Chain Foundations Certification
Build a stronger understanding of the people, processes, terminology, and decisions that shape how healthcare supply chain actually works.